Udayavni Special

Pfizer-BioNTech to seek authorisation for 3rd Covid shot: Statement


PTI, Jul 9, 2021, 9:39 AM IST

New Delhi: Pfizer and BioNTech announced Thursday they would seek regulatory authorization for a third dose of their Covid-19 vaccine.

It comes after initial data from an ongoing trial showed a third shot pushed antibody levels five to 10 times higher against the original coronavirus strain and the Beta variant, first found in South Africa, compared to the first two doses alone, according to a statement.

“The companies expect to publish more definitive data soon as well as in a peer-reviewed journal and plan to submit the data to the FDA (Food and Drug Administration), EMA (European Medicines Agency) and other regulatory authorities in the coming weeks,” the statement said.

In addition, the companies expect that a third dose will perform similarly well against the highly transmissible Delta strain, which is quickly becoming globally dominant.

Out of caution, the companies are also developing a Delta-specific vaccine, the first batch of which has been manufactured at BioNTech’s facility in Mainz, Germany.

The companies anticipate the clinical studies will begin in August, subject to regulatory approvals.

Based on drop-offs in efficacy seen in Israel after six months, the companies said they believe a third dose may be needed within six to 12 months after full vaccination

“While protection against severe disease remained high across the full 6 months, a decline in efficacy against symptomatic disease over time and the continued emergence of variants are expected,” the statement said.

The FDA and US Centers for Disease Control and Prevention released a joint statement late Thursday saying authorities were studying “whether or when a booster might be necessary.”

“Americans who have been fully vaccinated do not need a booster shot at this time,” the agencies said. “We are prepared for booster doses if and when the science demonstrates that they are needed.”

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Maravoor bridge opens for vehicular movement

BRICS finalises action plan to combat terrorism, radicalisation, terror financing

Doordarshan to share sign language bulletin with pvt TV news channels free of cost till Dec 31: Govt

Centre asks states, UTs to conduct special vaccination sessions for destitute, beggars

Italian marines: 7 fishermen move SC, seek share from Rs 2 cr compensation awarded to vessel owner

Chidambaram attacks govt over Pegasus, asks whether it will give up ‘ostrich-like attitude’

Surge in Covid-19 cases in Kerala: DC, Compol visit check post at Talapady


Related Articles More

ISRO-NASA joint satellite project NISER proposed to be launched early 2023, announces Jitendra Singh

International court drops arrest warrant against fmr Ivory Coast president’s wife

Heavy rains in Peshawar damage ancestral houses of Raj Kapoor, Dilip Kumar

US to conduct rare 2nd lottery for H-1B visa applicants

Blinken’s meeting with Dalai Lama representatives riles China

MUST WATCH

Seedless Persian Lime facts and Health benefits

SAKSLESHPURA BRIBING CAUGHT RED HANDED

|Udayavani news bulletin 30-07-2021

THE HONEYTRAPPING INDUSTRY

i was a Kannadiga in my previous birth | Happy Birthday Sonu Nigam | Udayavani

Latest Additions

Maravoor bridge opens for vehicular movement

BRICS finalises action plan to combat terrorism, radicalisation, terror financing

Doordarshan to share sign language bulletin with pvt TV news channels free of cost till Dec 31: Govt

Centre asks states, UTs to conduct special vaccination sessions for destitute, beggars

Italian marines: 7 fishermen move SC, seek share from Rs 2 cr compensation awarded to vessel owner

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.